It’s never a good day to be a lab rat, but today, it’s a slightly less bad day. And it’s a terrible day to be a stockholder of Charles River Labs, the company that conducts animal studies for much of the pharmaceutical industry. Its stock plummeted nearly 30% in about 30 minutes Thursday afternoon.